Executive Board
Programme
Join the global vascular and endovascular community
Charing Cross (CX) Symposium 2027 returns for its 49th year on 6 – 8 April 2027 at Olympia, London. Come and join us as we welcome the largest international community of clinicians, educators, innovators and industry partners in vascular disease management.
Across three days, CX Symposium will feature a physician-led scientific programme built around lively debate, peer-to-peer exchange, and an audience as expert as those presenting. With 500+ presentations, 300+ discussions, hands-on workshops, podium-first data, live and edited cases and an exhibition, CX Symposium brings together international speakers and the future leaders of vascular care to interrogate the evolving evidence base and its practical implications for best patient outcomes.
Registration opens soon.
CX Co-Chairs
Latest CX news
CX 2018: Landmark EVRA trial provides first Level 1 evidence for early endovenous ablation
The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium yesterday. The presentation was accompanied by simultaneous publication in the New England Journal of [...]
Majority of CX audience decides endovascular-first strategy for critical limb ischaemia is a concept without evidence
At the CX Great Debate held yesterday, vascular and endovascular surgery titans went head-to-head to debate the contentious topic “Endovascular-first strategy for critical limb ischaemia is a concept without evidence”. Arguing in favour of [...]
Drug-coated balloon is “highly effective and safe” and shows outstanding clinical improvement for patients compared to an uncoated balloon
Ulf Teichgraeber The 12-month results from the full clinical cohort of the EffPAC randomised controlled trial, were presented for the first time at the CX Symposium yesterday. Target lesion revascularisation at 12 [...]